Filing Details

Accession Number:
0000899243-20-028512
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-16 17:00:08
Reporting Period:
2020-08-21
Accepted Time:
2020-10-16 17:00:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1802665 Harmony Biosciences Holdings Inc. HRMY Pharmaceutical Preparations (2834) 822279923
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1821461 Ii Trust Fund Marshman 330 N. Wabash Ave, Suite 300
Chicago IL 60611
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-21 339,476 $24.00 10,651,120 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. On September 4, 2020, the reporting person filed a Form 4 amendment that incorrectly stated the number of shares of common stock beneficially owned after the reported transaction. Following the transactions reported hereing, as of August 21, 2020, the reporting person owned 10,651,120 shares of Common Stock.